Reuters logo
BRIEF-Novartis says Tasigna receives EU approval for inclusion of TFR data in product label
June 6, 2017 / 5:21 AM / 4 months ago

BRIEF-Novartis says Tasigna receives EU approval for inclusion of TFR data in product label

June 6 (Reuters) - Novartis Ag

* Novartis drug Tasigna receives EU approval for inclusion of treatment-free remission (TFR) data in product label Source text for Eikon: Further company coverage: (Reporting By Zurich newsroom)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below